Bruce Wyse

1.3k total citations
34 papers, 1.1k citations indexed

About

Bruce Wyse is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Bruce Wyse has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 14 papers in Cellular and Molecular Neuroscience and 11 papers in Molecular Biology. Recurrent topics in Bruce Wyse's work include Pain Mechanisms and Treatments (19 papers), Neuropeptides and Animal Physiology (14 papers) and Receptor Mechanisms and Signaling (5 papers). Bruce Wyse is often cited by papers focused on Pain Mechanisms and Treatments (19 papers), Neuropeptides and Animal Physiology (14 papers) and Receptor Mechanisms and Signaling (5 papers). Bruce Wyse collaborates with scholars based in Australia, Germany and Ireland. Bruce Wyse's co-authors include Maree T. Smith, John F. Hancock, Sandrine Roy, Stephen R. Edwards, Peter J. Cabot, Conrad Sernia, Arjun Muralidharan, Sarah J. Roberts‐Thomson, Gregory R. Monteith and Irina Vetter and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Bruce Wyse

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Wyse Australia 20 592 428 358 183 142 34 1.1k
Hiroki Yokoo Japan 23 735 1.2× 205 0.5× 302 0.8× 78 0.4× 101 0.7× 56 1.4k
Valeriy V. Lyzogubov United States 19 503 0.8× 566 1.3× 141 0.4× 113 0.6× 43 0.3× 36 1.5k
Sabina Frascarelli Italy 16 595 1.0× 343 0.8× 262 0.7× 48 0.3× 122 0.9× 41 1.2k
Diego Varela Chile 21 825 1.4× 213 0.5× 385 1.1× 73 0.4× 196 1.4× 47 1.5k
K. C. Dines United Kingdom 20 187 0.3× 828 1.9× 162 0.5× 171 0.9× 105 0.7× 32 1.4k
Hideyo Ohshika Japan 17 580 1.0× 167 0.4× 298 0.8× 82 0.4× 171 1.2× 96 1.0k
Njanoor Narayanan Canada 23 1.1k 1.9× 232 0.5× 307 0.9× 101 0.6× 846 6.0× 61 1.7k
Emel Songu‐Mize United States 17 514 0.9× 208 0.5× 129 0.4× 31 0.2× 186 1.3× 40 1.0k
K. Fujimoto Japan 18 415 0.7× 225 0.5× 109 0.3× 49 0.3× 73 0.5× 50 1.3k
Katrina MacAulay United Kingdom 14 900 1.5× 175 0.4× 151 0.4× 138 0.8× 99 0.7× 15 1.3k

Countries citing papers authored by Bruce Wyse

Since Specialization
Citations

This map shows the geographic impact of Bruce Wyse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Wyse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Wyse more than expected).

Fields of papers citing papers by Bruce Wyse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Wyse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Wyse. The network helps show where Bruce Wyse may publish in the future.

Co-authorship network of co-authors of Bruce Wyse

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Wyse. A scholar is included among the top collaborators of Bruce Wyse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Wyse. Bruce Wyse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuo, Andy, Åsa Andersson, Bruce Wyse, et al.. (2020). In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile. European Journal of Pharmacology. 872. 172947–172947. 12 indexed citations
2.
Han, Felicity Y., Bruce Wyse, & Maree T. Smith. (2014). Optimization and pharmacological characterization of a refined cisplatin-induced rat model of peripheral neuropathic pain. Behavioural Pharmacology. 25(8). 732–740. 34 indexed citations
3.
Cai, Jun, Yu Ma, Bruce Wyse, et al.. (2014). Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activity. Bioorganic & Medicinal Chemistry. 22(7). 2208–2219. 12 indexed citations
4.
Smith, Maree T., et al.. (2014). Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy. Behavioural Pharmacology. 25(2). 137–146. 25 indexed citations
5.
Muralidharan, Arjun, Bruce Wyse, & Maree T. Smith. (2013). Analgesic Efficacy and Mode of Action of a Selective Small Molecule Angiotensin II Type 2 Receptor Antagonist in a Rat Model of Prostate Cancer-Induced Bone Pain. Pain Medicine. 15(1). 93–110. 42 indexed citations
6.
Varamini, Pegah, Wei Huang Goh, Friederike M. Mansfeld, et al.. (2013). Peripherally acting novel lipo-endomorphin-1 peptides in neuropathic pain without producing constipation. Bioorganic & Medicinal Chemistry. 21(7). 1898–1904. 16 indexed citations
7.
Muralidharan, Arjun, Bruce Wyse, & Maree T. Smith. (2013). Optimization and characterization of a rat model of prostate cancer-induced bone pain using behavioral, pharmacological, radiological, histological and immunohistochemical methods. Pharmacology Biochemistry and Behavior. 106. 33–46. 25 indexed citations
8.
9.
Varamini, Pegah, Friederike M. Mansfeld, Joanne T. Blanchfield, et al.. (2012). Lipo-Endomorphin-1 Derivatives with Systemic Activity against Neuropathic Pain without Producing Constipation. PLoS ONE. 7(8). e41909–e41909. 30 indexed citations
10.
Varamini, Pegah, Friederike M. Mansfeld, Joanne T. Blanchfield, et al.. (2012). Synthesis and Biological Evaluation of an Orally Active Glycosylated Endomorphin-1. Journal of Medicinal Chemistry. 55(12). 5859–5867. 70 indexed citations
11.
12.
13.
Vetter, Irina, Wei Cheng, Madusha Peiris, et al.. (2008). Rapid, Opioid-sensitive Mechanisms Involved in Transient Receptor Potential Vanilloid 1 Sensitization. Journal of Biological Chemistry. 283(28). 19540–19550. 46 indexed citations
14.
Vetter, Irina, Bruce Wyse, Sarah J. Roberts‐Thomson, Gregory R. Monteith, & Peter J. Cabot. (2007). Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol. European Journal of Pain. 12(4). 441–454. 21 indexed citations
15.
Wyse, Bruce, Ian A. Prior, Hongwei Qian, et al.. (2003). Caveolin Interacts with the Angiotensin II Type 1 Receptor during Exocytic Transport but Not at the Plasma Membrane. Journal of Biological Chemistry. 278(26). 23738–23746. 108 indexed citations
16.
Carozzi, Amanda, Sandrine Roy, Isabel C. Morrow, et al.. (2002). Inhibition of Lipid Raft-dependent Signaling by a Dystrophy-associated Mutant of Caveolin-3. Journal of Biological Chemistry. 277(20). 17944–17949. 45 indexed citations
17.
Sernia, Conrad, et al.. (1997). Novel Perspectives on Pituitary and Brain Angiotensinogen. Frontiers in Neuroendocrinology. 18(2). 174–208. 24 indexed citations
18.
Wyse, Bruce & Conrad Sernia. (1997). Growth Hormone Regulates AT-1a Angiotensin Receptors in Astrocytes1. Endocrinology. 138(10). 4176–4180. 19 indexed citations
19.
Wyse, Bruce, et al.. (1995). Specific binding sites for (3–8) angiotensin in C6 glioma cells. Brain Research. 681(1-2). 41–46. 8 indexed citations
20.
Wyse, Bruce, et al.. (1993). Adrenoceptor-mediated cardiac and vascular responses in genetically growth hormone-deficient rats. Biochemical Pharmacology. 45(11). 2223–2229. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroki Yokoo Breakdown of academic impact, for papers by Valeriy V. Lyzogubov Breakdown of academic impact, for papers by Sabina Frascarelli Breakdown of academic impact, for papers by Diego Varela Breakdown of academic impact, for papers by K. C. Dines Breakdown of academic impact, for papers by Hideyo Ohshika Breakdown of academic impact, for papers by Njanoor Narayanan Breakdown of academic impact, for papers by Emel Songu‐Mize Breakdown of academic impact, for papers by K. Fujimoto Breakdown of academic impact, for papers by Katrina MacAulay
Rankless by CCL
2026